Widely prescribed, newer-generation antipsychotic drugs are no more effective for the treatment of schizophrenia in children and teens than older, cheaper drugs, a government-funded study shows.
Under the direction of the National Institute of Mental Health (NIMH), researchers compared two of the newer drugs, known as atypical antipsychotics, to an older-generation antipsychotic. They found no major differences in treatment outcomes, but big differences in side effects among young patients taking the newer and older drugs.
Newer Antipsychotics No Better in Kids
President-elect Donald Trump's choice to run the sprawling government agency that administers Medicare, Medicaid, and the...
Among the cast of characters poised to join the Trump administration, no one is as exasperating,...
Though seasonal illnesses like the flu are just starting to gain some traction, there’s one...
